Daniel D. Long

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Ran Xiao, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel D. Long:

Company Role Class Num Shares Value Price $ Report Date Ownership
Septerna, Inc. SVP, Drug Discovery Common Stock 92,911 $1,677,842 $18.06 10 Nov 2025 Direct
Septerna, Inc. SVP, Drug Discovery Stock Option (Right to Buy) 30,000 07 Aug 2025 Direct

Insider Reports Filed by Daniel D. Long

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SEPN Septerna, Inc. 10 Nov 2025 1 -$63,223 4 SVP, Drug Discovery 13 Nov 2025, 20:13
SEPN Septerna, Inc. 07 Aug 2025 1 $0 4 SVP, Drug Discovery 11 Aug 2025, 19:03
SEPN Septerna, Inc. 24 Oct 2024 0 $0 3 SVP, Drug Discovery 24 Oct 2024, 21:20